Versant Capital Management’s Axogen AXGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$24.8K Sell
591
-2
-0.3% -$90 ﹤0.01% 1839
2026
Q2
$27.4K Buy
593
+37
+7% +$1.49K ﹤0.01% 1758
2026
Q1
$18.4K Hold
556
– – ﹤0.01% 1857
2025
Q4
$18.2K Hold
556
– – ﹤0.01% 1697
2025
Q3
$9.9K Hold
556
– – ﹤0.01% 1940
2025
Q2
$6.03K Hold
556
– – ﹤0.01% 2092
2025
Q1
$10.3K Hold
556
– – ﹤0.01% 1715
2024
Q4
$9.16K Buy
+556
New +$7.87K ﹤0.01% 1447

Other funds holding AXGN

Versant Capital Management's AXGN Position: Q3 2026 in Review

Versant Capital Management reduced its Axogen (AXGN) stake by 0.34% in Q3 2026, selling an estimated $90 and leaving 591 shares worth $24.8K. The position accounts for ﹤0.01% of the portfolio, ranked #1839.

Versant Capital Management first reported a position in AXGN in Q4 2024 and has held it in 8 quarters since. The position peaked at $27.4K in Q2 2026. 124 funds tracked by Wall St. Rank hold AXGN as of Q3 2026.

  • Versant Capital Management held 591 shares of Axogen worth $24.8K as of Q3 2026.
  • Versant Capital Management sold 2 Axogen shares in Q3 2026, an estimated $90.
  • Axogen made up ﹤0.01% of Versant Capital Management's portfolio in Q3 2026, its #1839 holding.
  • Versant Capital Management first reported a position in Axogen in Q4 2024 and has held it in 8 quarters since.
  • Versant Capital Management's Axogen position peaked at $27.4K in Q2 2026.
  • 124 funds tracked by Wall St. Rank held Axogen as of Q3 2026.

Based on Versant Capital Management's 13F filing for Q3 2026, filed 2 Oct 2026.